Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Summary
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and health....
Infectious Disease Testing | Jan 31st, 2014 | by GlobalData
Bimmugen (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Summary
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healt....
Infectious Disease Testing | Jan 31st, 2014 | by GlobalData
Comvax (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Summary
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthc....
Infectious Disease Testing | Jan 31st, 2014 | by GlobalData
Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Summary
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and heal....
Infectious Disease Testing | Jan 31st, 2014 | by GlobalData
Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market
Summary
GBI Research, the leading business intelligence provider, has released its latest research A....
Infectious Disease Testing | Apr 20th, 2012 | by GBI Research
Facebook
Twitter
Google Plus
Linked In
RSS Feed
